Ausgabe 1/2016
Inhalt (19 Artikel)
To be young, Black, and living with breast cancer: a systematic review of health-related quality of life in young Black breast cancer survivors
Cleo A. Samuel, Laura C. Pinheiro, Katherine E. Reeder-Hayes, Jennifer S. Walker, Giselle Corbie-Smith, Shekinah A. Fashaw, Cheryl Woods-Giscombe, Stephanie B. Wheeler
The relationship between time to initiation of adjuvant chemotherapy and survival in breast cancer: a systematic review and meta-analysis
Michael J. Raphael, James J. Biagi, Weidong Kong, Mihaela Mates, Christopher M. Booth, William J. Mackillop
Inhibition of 6-phosphofructo-2-kinase (PFKFB3) suppresses glucose metabolism and the growth of HER2+ breast cancer
Julie O’Neal, Amy Clem, Lindsey Reynolds, Susan Dougherty, Yoannis Imbert-Fernandez, Sucheta Telang, Jason Chesney, Brian F. Clem
Use of a multiplexed immunoassay (PRO Onc assay) to detect HER2 abnormalities in circulating tumor cells of women with HER2-negative metastatic breast cancer: lack of response to HER2-targeted therapy
John D. Hainsworth, Patrick B. Murphy, Jose R. Alemar, Brooke R. Daniel, Robyn R. Young, Denise A. Yardley
ANG1005 for breast cancer brain metastases: correlation between 18F-FLT–PET after first cycle and MRI in response assessment
C. C. O’Sullivan, M. Lindenberg, C. Bryla, N. Patronas, C. J. Peer, L. Amiri-Kordestani, N. Davarpanah, E. M. Gonzalez, M. Burotto, P. Choyke, S. M. Steinberg, D. J. Liewehr, W. D. Figg, T. Fojo, S. Balasubramaniam, S. E. Bates
Evaluation of the effect of compression therapy using surgical gloves on nanoparticle albumin-bound paclitaxel-induced peripheral neuropathy: a phase II multicenter study by the Kamigata Breast Cancer Study Group
Shigeru Tsuyuki, Noriko Senda, Yookija Kanng, Ayane Yamaguchi, Hiroshi Yoshibayashi, Yuichiro Kikawa, Nobuyuki Katakami, Hironori Kato, Takashi Hashimoto, Toshitaka Okuno, Akira Yamauchi, Takashi Inamoto
Clinical implications of routine genomic mutation sequencing in PIK3CA/AKT1 and KRAS/NRAS/BRAF in metastatic breast cancer
Juan Miguel Cejalvo, J. Alejandro Pérez-Fidalgo, Gloria Ribas, Octavio Burgués, Cristina Mongort, Elisa Alonso, Maider Ibarrola-Villava, Begoña Bermejo, María Teresa Martínez, Andrés Cervantes, Ana Lluch
Initial experience of the BREAST-Q breast-conserving therapy module
Rachel L. O’Connell, Rosa DiMicco, Komel Khabra, Elizabeth A. O’Flynn, Nandita deSouza, Nicola Roche, Peter A. Barry, Anna M. Kirby, Jennifer E. Rusby
Inhibition of EGFR, HER2, and HER3 signaling with AZD8931 in combination with anastrozole as an anticancer approach: Phase II randomized study in women with endocrine-therapy-naïve advanced breast cancer
Stephen Johnston, Mark Basik, Roberto Hegg, Wirote Lausoontornsiri, Lukasz Grzeda, Mark Clemons, Lydia Dreosti, Helen Mann, Mary Stuart, Massimo Cristofanilli
Impact of androgen receptor expression in fluoxymesterone-treated estrogen receptor-positive metastatic breast cancer refractory to contemporary hormonal therapy
Miho Kono, Takeo Fujii, Genevieve Ray Lyons, Lei Huo, Roland Bassett, Yun Gong, Meghan Sri Karuturi, Debu Tripathy, Naoto T. Ueno
Trends and variation in the use of nipple-sparing mastectomy for breast cancer in the United States
Mark Sisco, Alexandra M. Kyrillos, Brittany R. Lapin, Chihsiung E. Wang, Katharine A. Yao
Haplotype analyses of the c.1027C>T and c.2167_2168delAT recurrent truncating mutations in the breast cancer-predisposing gene PALB2
Irene Catucci, Silvia Casadei, Yuan Chun Ding, Sara Volorio, Filomena Ficarazzi, Anna Falanga, Marina Marchetti, Carlo Tondini, Michela Franchi, Aaron Adamson, Jessica Mandell, Tom Walsh, Olufunmilayo I. Olopade, Siranoush Manoukian, Paolo Radice, Charite Ricker, Jeffrey Weitzel, Mary-Claire King, Paolo Peterlongo, Susan L. Neuhausen
Long-term outcome in young women with breast cancer: a population-based study
Hanna Fredholm, Kristina Magnusson, Linda S. Lindström, Hans Garmo, Sonja Eaker Fält, Henrik Lindman, Jonas Bergh, Lars Holmberg, Fredrik Pontén, Jan Frisell, Irma Fredriksson
Ten-year survival in women with primary stage IV breast cancer
Lee Guek Eng, Shaheenah Dawood, Victoria Sopik, Benjamin Haaland, Pui San Tan, Nirmala Bhoo-Pathy, Ellen Warner, Javaid Iqbal, Steven A. Narod, Rebecca Dent
Patterns of multidisciplinary care in the management of non-metastatic invasive breast cancer in the United States Medicare patient
Thomas M. Churilla, Brian L. Egleston, Colin T. Murphy, Elin R. Sigurdson, Shelly B. Hayes, Lori J. Goldstein, Richard J. Bleicher
Young adult breast cancer patients have a poor prognosis independent of prognostic clinicopathological factors: a study from the Japanese Breast Cancer Registry
Akemi Kataoka, Takayuki Iwamoto, Eriko Tokunaga, Ai Tomotaki, Hiraku Kumamaru, Hiroaki Miyata, Naoki Niikura, Masaaki Kawai, Keisei Anan, Naoki Hayashi, Shinobu Masuda, Koichiro Tsugawa, Kenjiro Aogi, Takanori Ishida, Hideji Masuoka, Kotaro Iijima, Takayuki Kinoshita, Seigo Nakamura, Yutaka Tokuda
Analysis of the breast cancer methylome using formalin-fixed paraffin-embedded tumour
Ee Ming Wong, JiHoon E. Joo, Catriona A. McLean, Laura Baglietto, Dallas R. English, Gianluca Severi, Hui-Chen Wu, Mary Beth Terry, John L. Hopper, Roger L. Milne, Graham G. Giles, Melissa C. Southey
EMSY copy number variation in male breast cancers characterized for BRCA1 and BRCA2 mutations
Anna Sara Navazio, Piera Rizzolo, Valentina Silvestri, Virginia Valentini, Veronica Zelli, Ines Zanna, Giovanna Masala, Simonetta Bianchi, Stefania Tommasi, Domenico Palli, Laura Ottini
Cost-effectiveness analysis of 1st through 3rd line sequential targeted therapy in HER2-positive metastatic breast cancer in the United States
Vakaramoko Diaby, Georges Adunlin, Askal A. Ali, Simon B. Zeichner, Gilberto de Lima Lopes, Christine G. Kohn, Alberto J. Montero